Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments

Among the four parasite species causing malaria in humans, Plasmodium vivax prevails on both the Asian and the American continents. Several antigens from this parasite’s erythrocytic stages have been characterised and some of them are considered to be good vaccine candidates. The P. vivax merozoite...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2003
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/28446
Acceso en línea:
https://doi.org/10.1016/S0264-410X(02)00660-6
https://repository.urosario.edu.co/handle/10336/28446
Palabra clave:
Plasmodium vivax
MSP-1
Binding
Polymorphism
Rights
License
Restringido (Acceso a grupos específicos)
id EDOCUR2_d69c49162196db746c33c64d5eb46836
oai_identifier_str oai:repository.urosario.edu.co:10336/28446
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 9a3085ce-8acf-49bd-9a08-5a846e97d68f-1bc790c1a-5555-40ba-8c5f-98ea85a9518f-18d1788a6-8d70-4475-ab63-5af1c6ad7a3c-11892baaf-e3bf-48aa-96a1-f2f609e426d8-1cdd23bc2-518b-4274-a680-f8596dcd26b5-16ac3582a-7e61-4496-9fe0-36f1f30525b8-11450e86b-c3ae-413a-bffa-4caa6fae204a-1af79179a-6b60-4e4c-bf91-422a3e83c570-1796530656002020-08-28T15:48:13Z2020-08-28T15:48:13Z2003-03-07Among the four parasite species causing malaria in humans, Plasmodium vivax prevails on both the Asian and the American continents. Several antigens from this parasite’s erythrocytic stages have been characterised and some of them are considered to be good vaccine candidates. The P. vivax merozoite surface protein-1 (PvMSP-1) is a 200 kDa antigen, thought to mediate the initial contact between the merozoite and the erythrocyte. An effective blockage of this interaction could be important in anti-malarial vaccine design. This study analyses the genetic polymorphism, binding to both reticulocytes and erythrocytes, antigenicity and immunogenicity of two recombinant proteins belonging to the 33 kDa PvMSP-1 proteolytic fragment. Both regions showed very low genetic variation, bound reticulocytes with higher affinity than erythrocytes, were recognised by naturally P. vivax-infected patient sera and were immunogenic when used to immunise rabbits, making them good vaccine candidates against P. vivax, to be further preclinically tested in the Aotus monkey model.application/pdfhttps://doi.org/10.1016/S0264-410X(02)00660-6ISSN: 0264-410XEISSN: 1873-2518https://repository.urosario.edu.co/handle/10336/28446engElsevier1043No. 11–121033VaccineVol. 21Vaccine, ISSN: 0264-410X;EISSN: 1873-2518, Vol. 21, No. 11–12 (7 March 2003); pp. 1033-1043https://www.sciencedirect.com/science/article/pii/S0264410X02006606?via%3DihubRestringido (Acceso a grupos específicos)http://purl.org/coar/access_right/c_16ecVaccineinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURPlasmodium vivaxMSP-1BindingPolymorphismExpression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragmentsExpresión, análisis de polimorfismo, unión de reticulocitos y reactividad serológica de dos fragmentos recombinantes de la proteína Plasmodium vivax MSP-1articleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Espinosa, Ana Mar??aSierra, Adriana YanettBarrero, Carlos AlbertoCepeda, Libia AlexandraCantor, Elvia Mar??aLombo, Tania BibianaGuzmán, FannyAvila, Sandra JulietaPatarroyo, Manuel A.10336/28446oai:repository.urosario.edu.co:10336/284462021-06-03 00:49:49.098https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments
dc.title.TranslatedTitle.spa.fl_str_mv Expresión, análisis de polimorfismo, unión de reticulocitos y reactividad serológica de dos fragmentos recombinantes de la proteína Plasmodium vivax MSP-1
title Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments
spellingShingle Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments
Plasmodium vivax
MSP-1
Binding
Polymorphism
title_short Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments
title_full Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments
title_fullStr Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments
title_full_unstemmed Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments
title_sort Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments
dc.subject.keyword.spa.fl_str_mv Plasmodium vivax
MSP-1
Binding
Polymorphism
topic Plasmodium vivax
MSP-1
Binding
Polymorphism
description Among the four parasite species causing malaria in humans, Plasmodium vivax prevails on both the Asian and the American continents. Several antigens from this parasite’s erythrocytic stages have been characterised and some of them are considered to be good vaccine candidates. The P. vivax merozoite surface protein-1 (PvMSP-1) is a 200 kDa antigen, thought to mediate the initial contact between the merozoite and the erythrocyte. An effective blockage of this interaction could be important in anti-malarial vaccine design. This study analyses the genetic polymorphism, binding to both reticulocytes and erythrocytes, antigenicity and immunogenicity of two recombinant proteins belonging to the 33 kDa PvMSP-1 proteolytic fragment. Both regions showed very low genetic variation, bound reticulocytes with higher affinity than erythrocytes, were recognised by naturally P. vivax-infected patient sera and were immunogenic when used to immunise rabbits, making them good vaccine candidates against P. vivax, to be further preclinically tested in the Aotus monkey model.
publishDate 2003
dc.date.created.spa.fl_str_mv 2003-03-07
dc.date.accessioned.none.fl_str_mv 2020-08-28T15:48:13Z
dc.date.available.none.fl_str_mv 2020-08-28T15:48:13Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/S0264-410X(02)00660-6
dc.identifier.issn.none.fl_str_mv ISSN: 0264-410X
EISSN: 1873-2518
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/28446
url https://doi.org/10.1016/S0264-410X(02)00660-6
https://repository.urosario.edu.co/handle/10336/28446
identifier_str_mv ISSN: 0264-410X
EISSN: 1873-2518
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 1043
dc.relation.citationIssue.none.fl_str_mv No. 11–12
dc.relation.citationStartPage.none.fl_str_mv 1033
dc.relation.citationTitle.none.fl_str_mv Vaccine
dc.relation.citationVolume.none.fl_str_mv Vol. 21
dc.relation.ispartof.spa.fl_str_mv Vaccine, ISSN: 0264-410X;EISSN: 1873-2518, Vol. 21, No. 11–12 (7 March 2003); pp. 1033-1043
dc.relation.uri.spa.fl_str_mv https://www.sciencedirect.com/science/article/pii/S0264410X02006606?via%3Dihub
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_16ec
dc.rights.acceso.spa.fl_str_mv Restringido (Acceso a grupos específicos)
rights_invalid_str_mv Restringido (Acceso a grupos específicos)
http://purl.org/coar/access_right/c_16ec
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier
dc.source.spa.fl_str_mv Vaccine
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167503457222656